We thought that the IFN-γ dose used might not be enough to cause hypoglycemia; we treated those animals with a dose of IFN-γ as high as 6 times of serum IFN-γ levels at six hours after anti-CD3 treatment. Here, IFNG is linked to Hypoglycemia.